Fmoc-(R)-3-Amino-3-(3-methoxyphenyl)pr opionic acid, 97%, 1g

2-{1-[(tert-butoxy)carbonyl]azetidin-3-yl}benzoic acid, 97%, 25mg

4-Chloro-8-(trifluoromethyl)quinoline-3-carboxylic acid ethyl ester, 97%, 1g

Dihidrato de complexona de alizarina, mínimo 97 %, pa, 1 g, envase de vidrio

3-Bromo-5,6,7,8-tetrahydro-1,6-naphthyridine hydrochloride, 95.0%, 100mg

ETHYL 8-BROMOIMIDAZO[1,2-A]PYRIDINE-3-CARBOXYLATE, 95.0%, 1g

4-Methoxypyridine, 98.0%, 100g

3-Amino-2,5-dimethylbenzonitrile, 97.0%, 100mg

6-Methoxy-1-indanone, 98.0%, 5g

TETRAKIS(4-CYANOPHENYL)METHANE, 95%, 250mg

2-Fluorobenzenethiol>98.0%(GC)5g

3-Fluoro-5-methylbenzyl bromide, 25g

6-Amino-3,4-dihydroquinolin-2(1H)-one, 95.0%, 250mg